
Midatech Pharma plc MTP
Annual report 2024
added 02-21-2026
Midatech Pharma plc Cash Conversion Cycle 2011-2026 | MTP
Annual Cash Conversion Cycle Midatech Pharma plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 82.8 | -8.54 K | - | - | - | - |
All numbers in GBP currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 82.8 | -8.54 K | -4.23 K |
Cash Conversion Cycle of other stocks in the Biotechnology industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
I-Mab
IMAB
|
-1.97 K | - | - | $ 866 M | ||
|
Grifols, S.A.
GRFS
|
0.000171 | $ 9.0 | 0.47 % | $ 6.83 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
AgeX Therapeutics
AGE
|
-8.96 K | - | -10.17 % | $ 12.2 K | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | ||
|
Acorda Therapeutics
ACOR
|
117 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
ADMA Biologics
ADMA
|
355 | $ 15.38 | 1.32 % | $ 3.67 B | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
72.3 | $ 16.0 | -2.79 % | $ 2.43 B | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
-1.55 K | - | -0.23 % | $ 916 M | ||
|
Alkermes plc
ALKS
|
299 | $ 30.02 | -2.31 % | $ 4.94 B | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Aeterna Zentaris
AEZS
|
-34.3 K | - | 5.93 % | $ 314 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-2.85 K | - | -11.43 % | $ 502 K | ||
|
Amphastar Pharmaceuticals
AMPH
|
205 | $ 20.19 | -23.78 % | $ 944 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Aridis Pharmaceuticals
ARDS
|
59 | - | 17.91 % | $ 11.1 M | ||
|
Arena Pharmaceuticals
ARNA
|
946 | - | -6.81 % | $ 3.04 B | ||
|
Aurinia Pharmaceuticals
AUPH
|
612 | $ 14.1 | 0.89 % | $ 1.89 B | ||
|
Axsome Therapeutics
AXSM
|
-256 | $ 163.5 | 0.19 % | $ 8.13 B | ||
|
Aytu BioScience
AYTU
|
174 | $ 2.57 | 4.47 % | $ 16.1 M |